IFIH1 and interstitial lung disease: Patients with clinically amyopathic dermatomyositis (CADM) with anti-Melanoma Differentiation-Associated gene 5 (MDA5) antibody often develop treatment-resistant, and rapidly-progressive interstitial lung disease (RP-ILD) [1].